GFR alpha-1

GFR alpha-1

GFR alpha-1 Molekülinformation

Molecule Name
Glial cell line-derived neurotrophic factor receptors
Molekülalias
GFRA1,GDNFRA,RETL1,TRNR1,GDNFR,GFR-ALPHA-1,RET1L
Drug Development Progress
Anzahl der klinischen Arzneimittel3
Anzahl der inverkehr gebrachten Arzneimittel0
Höchste Forschungs- und EntwicklungsphasePhase 2 Clinical
Target-Alias
Glial Cell Line-Derived Neurotrophic Factor Receptors
Molekülhintergrund
GDNF family receptor alpha-1 (GFRA1) is also known as RET ligand 1 (RETL1), TGF-beta-related neurotrophic factor receptor 1 (TRNR1), is a novel glycosylphosphatidylinositol (GPI)-linked cell surface receptor, and belongs to the glial cell line-derived neurotrophic factor (GDNF) receptor subfamily. The GDNF family ligands comprises GDNF, Neurturin (NTN), Artemin, and Persephin. GDNF and NTN are two structurally related, potent neurotrophic factors that play key roles in the control of neuron survival and differentiation. GFRA1 mediates the association with and activation of the RET tyrosine kinase receptor (RTK), and subsequently initiates the RET signaling pathway. GFR alpha-mediated signaling plays an important role in the survival, differentiation, and migration of central and peripheral neurons, and is essential for the development of kidneys and the enteric nervous system, as well as the inflammatory response in some carciniomas.

GFR alpha-1 Produktliste

Species
  • Human(1)
Tag
  • His Tag(1)
Host
  • HEK293(1)
Conjugate
  • Unconjugated(1)
Grade
  • RUO(1)
Low Endotoxin
  • No(1)
MoleculeCat. No.Product NameArtHostStructurePurityActivitySize&PriceAdd to Cart
GFR alpha-1
Human GFR alpha-1 Protein, His Tag
Human
HEK293
SDS-PAGE
ELISA

$300.00

100ug
You Have Viewed 1-1 Of 1 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity
Resources

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
KLS-2031KLS-2031Phase 2 ClinicalKolon Life Science. Inc
Neuralgia; Radiculopathy
Details
NGM-386NGM-386Phase 1 ClinicalNGM Biopharmaceuticals Inc
Obesity
Details
NGM-395NGM-395Phase 1 ClinicalNGM Biopharmaceuticals Inc
Metabolic Dysfunction-Associated Steatotic Liver Disease; Obesity
Details
Customer Reviews